-
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a British-Swedish
multinational pharmaceutical and
biotechnology company with its
headquarters at the Cambridge...
- The Oxford–
AstraZeneca COVID‑19 vaccine, sold
under the
brand names Covishield and
Vaxzevria among others, is a
viral vector vaccine for the prevention...
-
recognized by the
World Health Organization (WHO): Pfizer–BioNTech, Oxford–
AstraZeneca,
Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia...
- results" (PDF).
AstraZeneca. "Full year and Q4 2023 results" (PDF).
AstraZeneca. "Full year and Q4 2022 results" (PDF).
AstraZeneca. "Full year and Q4...
- by
Swedish AB Hässle, part of
Astra AB. It was the
first of the
proton pump
inhibitors (PPI).
Astra AB, now
AstraZeneca,
launched it as an
ulcer medicine...
- PMC 8143907. PMID 34062319. "
AstraZeneca COVID-19
Vaccine (AZD1222)" (PDF). ACIP COVID-19
Emergency Meeting.
AstraZeneca. 27
January 2021.
Archived (PDF)...
- Biovail's sustained-release
tablets will
compete with
AstraZeneca's Seroquel XR. In
December 2008,
AstraZeneca notified shareholders that the FDA had
asked for...
-
Canada authorized the Oxford–
AstraZeneca vaccine for use.
Following concerns of
blood clotting events the Oxford-
AstraZeneca vaccine was
largely discontinued...
- This was amid
concerns about the
AstraZeneca vaccine, in rare cases,
causing blood clots; see
section Oxford–
AstraZeneca vaccine below. The
additional doses...
-
Astra was
formed in 1913 and
merged with the
British Zeneca Group in 1999 to form
AstraZeneca.
Product development was
focused on
therapeutics for gastrointestinal...
